Structure and thermodynamic characterization of the EphB4/ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity

被引:80
作者
Chrencik, JE
Brooun, A
Recht, MI
Kraus, ML
Koolpe, M
Kolatkar, AR
Bruce, RH
Martiny-Baron, G
Widmer, H
Pasquale, EB
Kuhn, P
机构
[1] Scripps Res Inst, Dept Cellular Biol, La Jolla, CA 92037 USA
[2] Burnham Inst Med Res, La Jolla, CA 92037 USA
[3] Scripps PARC Inst Adv Biomed Sci, Palo Alto Res Ctr, Palo Alto, CA 94304 USA
[4] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.str.2005.11.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Eph receptor tyrosine kinases and their ligands, the ephrins, regulate numerous biological processes in developing and adult tissues and have been implicated in cancer progression and in pathological forms of angiogenesis. We report the crystal structure of the EphB4 receptor in complex with a highly specific antagonistic peptide at a resolution of 1.65 angstrom. The peptide is situated in a hydrophobic cleft of EphB4 corresponding to the cleft in EphB2 occupied by the ephrin-132 G-H loop, consistent with its antagonistic properties. Structural analysis identifies several residues within the EphB4 binding cleft that likely determine the ligand specificity of this receptor, while isothermal titration calorimetry experiments with truncated forms of the peptide define the amino acid residues of the peptide that are critical for receptor binding. These studies reveal structural features that will aid drug discovery initiatives to develop EphB4 antagonists for therapeutic applications.
引用
收藏
页码:321 / 330
页数:10
相关论文
共 40 条
[1]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[2]  
[Anonymous], 1997, Cell, V90, P403
[3]   Eph receptor tyrosine kinases in angiogenesis: From development to disease [J].
Brantley-Sieders D.M. ;
Chen J. .
Angiogenesis, 2004, 7 (1) :17-28
[4]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[5]  
Carmeliet P, 1999, CURR TOP MICROBIOL, V237, P133
[6]   The ephrins and Eph receptors in angiogenesis [J].
Cheng, N ;
Brantley, DM ;
Chen, J .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (01) :75-85
[7]   Eph receptors and ephrin ligands: embryogenesis to tumorigenesis [J].
Dodelet, VC ;
Pasquale, EB .
ONCOGENE, 2000, 19 (49) :5614-5619
[8]   An extensively modified version of MolScript that includes greatly enhanced coloring capabilities [J].
Esnouf, RM .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1997, 15 (02) :132-+
[9]  
Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1
[10]   Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells [J].
Füller, T ;
Korff, T ;
Kilian, A ;
Dandekar, G ;
Augustin, HG .
JOURNAL OF CELL SCIENCE, 2003, 116 (12) :2461-2470